Truist Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.3M | Buy |
45,234
+5,136
| +13% | +$829K | 0.01% | 692 |
|
|
2025
Q1 | $6.82M | Buy |
40,098
+609
| +2% | +$104K | 0.01% | 695 |
|
|
2024
Q4 | $6.56M | Sell |
39,489
-5,353
| -12% | -$890K | 0.01% | 715 |
|
|
2024
Q3 | $7.71M | Buy |
44,842
+272
| +0.6% | +$46.8K | 0.01% | 667 |
|
|
2024
Q2 | $6.86M | Buy |
44,570
+2,320
| +5% | +$357K | 0.01% | 734 |
|
|
2024
Q1 | $6.5M | Buy |
42,250
+2,515
| +6% | +$387K | 0.01% | 779 |
|
|
2023
Q4 | $6.28M | Buy |
39,735
+6,782
| +21% | +$1.07M | 0.01% | 785 |
|
|
2023
Q3 | $4.82M | Buy |
32,953
+1,492
| +5% | +$218K | 0.01% | 852 |
|
|
2023
Q2 | $4.82M | Buy |
31,461
+5,977
| +23% | +$915K | 0.01% | 845 |
|
|
2023
Q1 | $3.95M | Sell |
25,484
-8,536
| -25% | -$1.32M | 0.01% | 919 |
|
|
2022
Q4 | $5.24M | Sell |
34,020
-9,409
| -22% | -$1.45M | 0.01% | 803 |
|
|
2022
Q3 | $5.73M | Buy |
43,429
+17,791
| +69% | +$2.35M | 0.01% | 725 |
|
|
2022
Q2 | $3.48M | Buy |
25,638
+1,069
| +4% | +$145K | 0.01% | 946 |
|
|
2022
Q1 | $3.66M | Sell |
24,569
-281
| -1% | -$41.9K | 0.01% | 1003 |
|
|
2021
Q4 | $4.03M | Sell |
24,850
-17,445
| -41% | -$2.83M | 0.01% | 967 |
|
|
2021
Q3 | $7.02M | Buy |
42,295
+12,853
| +44% | +$2.13M | 0.01% | 758 |
|
|
2021
Q2 | $5.08M | Sell |
29,442
-5,903
| -17% | -$1.02M | 0.01% | 873 |
|
|
2021
Q1 | $5.67M | Sell |
35,345
-246
| -0.7% | -$39.5K | 0.01% | 797 |
|
|
2020
Q4 | $5.98M | Sell |
35,591
-4,530
| -11% | -$761K | 0.01% | 753 |
|
|
2020
Q3 | $6.31M | Sell |
40,121
-9,290
| -19% | -$1.46M | 0.01% | 683 |
|
|
2020
Q2 | $8.29M | Buy |
49,411
+7,270
| +17% | +$1.22M | 0.02% | 576 |
|
|
2020
Q1 | $5.53M | Buy |
42,141
+12,607
| +43% | +$1.65M | 0.01% | 645 |
|
|
2019
Q4 | $4.39M | Buy |
+29,534
| New | +$4.39M | 0.01% | 793 |
|